Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Artificial Intelligence | 16 | 2025 | 173 | 7.920 |
Why?
|
| Radiology | 19 | 2025 | 233 | 6.740 |
Why?
|
| Tomography, X-Ray Computed | 20 | 2022 | 1480 | 2.390 |
Why?
|
| Lung Neoplasms | 12 | 2023 | 577 | 2.380 |
Why?
|
| Societies, Medical | 8 | 2025 | 341 | 1.620 |
Why?
|
| Early Detection of Cancer | 10 | 2023 | 272 | 1.520 |
Why?
|
| Radiology Department, Hospital | 4 | 2020 | 24 | 1.430 |
Why?
|
| Algorithms | 5 | 2024 | 1001 | 1.160 |
Why?
|
| Diagnostic Imaging | 4 | 2024 | 242 | 1.060 |
Why?
|
| Diagnostic Errors | 2 | 2019 | 98 | 1.050 |
Why?
|
| Technology, Radiologic | 2 | 2014 | 9 | 0.960 |
Why?
|
| Breast Density | 1 | 2024 | 16 | 0.940 |
Why?
|
| Accreditation | 1 | 2025 | 74 | 0.940 |
Why?
|
| Medical Informatics | 2 | 2014 | 68 | 0.910 |
Why?
|
| Information Dissemination | 2 | 2021 | 119 | 0.870 |
Why?
|
| Humans | 53 | 2025 | 60049 | 0.830 |
Why?
|
| Mammography | 1 | 2024 | 273 | 0.780 |
Why?
|
| Privacy | 1 | 2021 | 11 | 0.770 |
Why?
|
| Radiography | 6 | 2023 | 514 | 0.750 |
Why?
|
| Commerce | 1 | 2022 | 59 | 0.750 |
Why?
|
| Trust | 1 | 2021 | 68 | 0.720 |
Why?
|
| Machine Learning | 2 | 2021 | 151 | 0.720 |
Why?
|
| Radiology Information Systems | 3 | 2014 | 31 | 0.690 |
Why?
|
| Hospital Administrators | 1 | 2019 | 10 | 0.660 |
Why?
|
| Software | 3 | 2024 | 373 | 0.640 |
Why?
|
| United States | 16 | 2025 | 7595 | 0.640 |
Why?
|
| Organizational Culture | 1 | 2019 | 111 | 0.620 |
Why?
|
| Electronic Health Records | 1 | 2022 | 354 | 0.620 |
Why?
|
| Radiation Dosage | 3 | 2021 | 130 | 0.590 |
Why?
|
| Safety Management | 1 | 2019 | 143 | 0.590 |
Why?
|
| Mass Screening | 5 | 2018 | 662 | 0.590 |
Why?
|
| Diagnosis-Related Groups | 1 | 2017 | 87 | 0.550 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 104 | 0.540 |
Why?
|
| Breast Neoplasms | 1 | 2024 | 1128 | 0.510 |
Why?
|
| Patient Selection | 3 | 2013 | 453 | 0.510 |
Why?
|
| Internet | 2 | 2021 | 463 | 0.500 |
Why?
|
| Quality Assurance, Health Care | 4 | 2025 | 248 | 0.490 |
Why?
|
| Patient Compliance | 1 | 2017 | 372 | 0.490 |
Why?
|
| Liver Transplantation | 4 | 2012 | 193 | 0.460 |
Why?
|
| Inpatients | 1 | 2017 | 300 | 0.460 |
Why?
|
| Stroke | 1 | 2023 | 1143 | 0.450 |
Why?
|
| Neoplasm Staging | 3 | 2018 | 458 | 0.440 |
Why?
|
| Reproducibility of Results | 6 | 2024 | 1565 | 0.440 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2014 | 167 | 0.430 |
Why?
|
| Delivery of Health Care | 3 | 2022 | 424 | 0.430 |
Why?
|
| Retrospective Studies | 12 | 2024 | 6125 | 0.410 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2011 | 168 | 0.410 |
Why?
|
| Smoking | 2 | 2014 | 835 | 0.400 |
Why?
|
| Peer Review | 2 | 2023 | 25 | 0.390 |
Why?
|
| Liver Neoplasms | 2 | 2011 | 278 | 0.380 |
Why?
|
| Advisory Committees | 1 | 2011 | 107 | 0.360 |
Why?
|
| Living Donors | 2 | 2012 | 65 | 0.350 |
Why?
|
| Publishing | 1 | 2011 | 91 | 0.350 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2023 | 2049 | 0.340 |
Why?
|
| Decision Support Techniques | 1 | 2011 | 182 | 0.330 |
Why?
|
| Radiologists | 4 | 2023 | 75 | 0.330 |
Why?
|
| Cholangiography | 1 | 2008 | 42 | 0.320 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2008 | 9 | 0.320 |
Why?
|
| Periodicals as Topic | 1 | 2011 | 174 | 0.310 |
Why?
|
| Biliary Tract Diseases | 1 | 2008 | 18 | 0.310 |
Why?
|
| Health Services Accessibility | 1 | 2013 | 543 | 0.300 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2007 | 16 | 0.290 |
Why?
|
| Hepatectomy | 2 | 2012 | 59 | 0.280 |
Why?
|
| Coronary Angiography | 1 | 2007 | 177 | 0.270 |
Why?
|
| Patient Care Planning | 1 | 2006 | 84 | 0.250 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2021 | 570 | 0.240 |
Why?
|
| Proof of Concept Study | 1 | 2024 | 35 | 0.240 |
Why?
|
| Capital Financing | 1 | 2023 | 3 | 0.220 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2006 | 272 | 0.220 |
Why?
|
| Middle Aged | 11 | 2021 | 16503 | 0.220 |
Why?
|
| Female | 12 | 2024 | 31193 | 0.220 |
Why?
|
| Hospitalization | 2 | 2021 | 1301 | 0.220 |
Why?
|
| Colorectal Neoplasms | 1 | 2006 | 259 | 0.210 |
Why?
|
| Male | 14 | 2021 | 27916 | 0.210 |
Why?
|
| Computers | 1 | 2023 | 48 | 0.210 |
Why?
|
| Teaching | 1 | 2004 | 157 | 0.210 |
Why?
|
| Efficiency, Organizational | 2 | 2020 | 95 | 0.200 |
Why?
|
| Triage | 1 | 2023 | 111 | 0.200 |
Why?
|
| Edema | 1 | 2022 | 41 | 0.200 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 638 | 0.200 |
Why?
|
| Lung | 3 | 2023 | 841 | 0.200 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2023 | 94 | 0.190 |
Why?
|
| Electronics | 1 | 2022 | 37 | 0.190 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 1 | 2021 | 10 | 0.190 |
Why?
|
| Hepatic Veno-Occlusive Disease | 1 | 2021 | 1 | 0.190 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 2021 | 75 | 0.190 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2021 | 11 | 0.190 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 1100 | 0.190 |
Why?
|
| Vascular Calcification | 1 | 2021 | 21 | 0.180 |
Why?
|
| Patient Safety | 1 | 2024 | 244 | 0.180 |
Why?
|
| Myocardial Infarction | 1 | 2007 | 867 | 0.180 |
Why?
|
| Pectoralis Muscles | 1 | 2020 | 5 | 0.180 |
Why?
|
| Emphysema | 1 | 2020 | 30 | 0.180 |
Why?
|
| Radiology, Interventional | 1 | 2020 | 29 | 0.180 |
Why?
|
| Informed Consent | 1 | 2021 | 133 | 0.180 |
Why?
|
| Diverticulitis, Colonic | 2 | 2011 | 32 | 0.170 |
Why?
|
| Practice Guidelines as Topic | 3 | 2018 | 712 | 0.170 |
Why?
|
| Liver | 4 | 2021 | 788 | 0.170 |
Why?
|
| Risk Factors | 5 | 2018 | 5068 | 0.170 |
Why?
|
| Internship and Residency | 2 | 2005 | 746 | 0.170 |
Why?
|
| Liver Diseases | 1 | 2021 | 136 | 0.170 |
Why?
|
| Aged | 7 | 2021 | 13553 | 0.170 |
Why?
|
| Attitude of Health Personnel | 1 | 2004 | 564 | 0.170 |
Why?
|
| Decision Trees | 1 | 2019 | 52 | 0.160 |
Why?
|
| Professional Competence | 1 | 2019 | 89 | 0.160 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 2613 | 0.160 |
Why?
|
| Canada | 3 | 2024 | 150 | 0.150 |
Why?
|
| Pneumonia | 1 | 2021 | 272 | 0.150 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 275 | 0.150 |
Why?
|
| Neuroradiography | 1 | 2017 | 10 | 0.140 |
Why?
|
| Ultrasonography | 2 | 2011 | 460 | 0.140 |
Why?
|
| Massachusetts | 4 | 2020 | 2117 | 0.140 |
Why?
|
| Intracranial Aneurysm | 1 | 2020 | 343 | 0.130 |
Why?
|
| Predictive Value of Tests | 4 | 2012 | 1035 | 0.130 |
Why?
|
| Pandemics | 1 | 2021 | 629 | 0.130 |
Why?
|
| Comorbidity | 2 | 2020 | 1094 | 0.130 |
Why?
|
| Software Design | 1 | 2014 | 28 | 0.120 |
Why?
|
| Adult | 5 | 2023 | 15952 | 0.120 |
Why?
|
| Endovascular Procedures | 1 | 2020 | 576 | 0.120 |
Why?
|
| New Zealand | 2 | 2024 | 34 | 0.110 |
Why?
|
| Coronary Sinus | 1 | 2013 | 5 | 0.110 |
Why?
|
| Vascular Fistula | 1 | 2013 | 7 | 0.110 |
Why?
|
| Sex Distribution | 1 | 2014 | 255 | 0.110 |
Why?
|
| Age Distribution | 1 | 2014 | 262 | 0.110 |
Why?
|
| Lung Diseases | 1 | 2015 | 166 | 0.110 |
Why?
|
| Australia | 2 | 2024 | 95 | 0.110 |
Why?
|
| Child | 1 | 2023 | 4328 | 0.110 |
Why?
|
| Europe | 2 | 2024 | 184 | 0.110 |
Why?
|
| Length of Stay | 1 | 2017 | 779 | 0.110 |
Why?
|
| Heart Defects, Congenital | 1 | 2013 | 96 | 0.100 |
Why?
|
| Models, Organizational | 1 | 2013 | 93 | 0.100 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 327 | 0.100 |
Why?
|
| Quality Control | 1 | 2011 | 70 | 0.090 |
Why?
|
| Contrast Media | 2 | 2021 | 414 | 0.090 |
Why?
|
| Organizational Objectives | 1 | 2011 | 58 | 0.090 |
Why?
|
| Computer Simulation | 2 | 2020 | 458 | 0.090 |
Why?
|
| Incidence | 1 | 2014 | 1255 | 0.090 |
Why?
|
| Forecasting | 1 | 2011 | 221 | 0.090 |
Why?
|
| Risk | 2 | 2021 | 377 | 0.090 |
Why?
|
| Resource Allocation | 1 | 2010 | 20 | 0.090 |
Why?
|
| Prognosis | 2 | 2011 | 1589 | 0.080 |
Why?
|
| Tissue and Organ Procurement | 1 | 2010 | 37 | 0.080 |
Why?
|
| Patient Education as Topic | 1 | 2013 | 448 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 457 | 0.080 |
Why?
|
| Biomedical Research | 1 | 2011 | 251 | 0.080 |
Why?
|
| Primary Health Care | 1 | 2013 | 660 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 5181 | 0.070 |
Why?
|
| Organ Size | 2 | 2020 | 165 | 0.070 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2006 | 20 | 0.070 |
Why?
|
| Colonoscopy | 1 | 2006 | 104 | 0.060 |
Why?
|
| Models, Anatomic | 1 | 2006 | 59 | 0.060 |
Why?
|
| Positron-Emission Tomography | 1 | 2006 | 174 | 0.060 |
Why?
|
| Colon | 1 | 2006 | 139 | 0.060 |
Why?
|
| Rectal Neoplasms | 1 | 2006 | 98 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 910 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2021 | 1933 | 0.060 |
Why?
|
| Investments | 1 | 2023 | 2 | 0.060 |
Why?
|
| Mentors | 1 | 2005 | 119 | 0.060 |
Why?
|
| Academies and Institutes | 1 | 2023 | 22 | 0.060 |
Why?
|
| Physician's Role | 1 | 2005 | 120 | 0.050 |
Why?
|
| Academic Medical Centers | 1 | 2005 | 314 | 0.050 |
Why?
|
| Leadership | 1 | 2005 | 200 | 0.050 |
Why?
|
| Feedback | 1 | 2022 | 87 | 0.050 |
Why?
|
| Age Factors | 2 | 2020 | 1524 | 0.050 |
Why?
|
| Consensus | 1 | 2023 | 198 | 0.050 |
Why?
|
| Portal System | 1 | 2021 | 3 | 0.050 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2021 | 18 | 0.050 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2021 | 56 | 0.050 |
Why?
|
| Young Adult | 3 | 2021 | 4384 | 0.050 |
Why?
|
| United States Food and Drug Administration | 1 | 2021 | 95 | 0.050 |
Why?
|
| Documentation | 1 | 2022 | 129 | 0.050 |
Why?
|
| ROC Curve | 1 | 2021 | 259 | 0.050 |
Why?
|
| Abdominal Pain | 1 | 2021 | 94 | 0.050 |
Why?
|
| Computed Tomography Angiography | 1 | 2021 | 116 | 0.040 |
Why?
|
| Workflow | 1 | 2020 | 63 | 0.040 |
Why?
|
| Appointments and Schedules | 1 | 2020 | 54 | 0.040 |
Why?
|
| Body Composition | 1 | 2020 | 155 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2023 | 698 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2020 | 892 | 0.030 |
Why?
|
| Hamartoma | 1 | 2015 | 7 | 0.030 |
Why?
|
| Mediastinoscopy | 1 | 2015 | 7 | 0.030 |
Why?
|
| Thoracotomy | 1 | 2015 | 46 | 0.030 |
Why?
|
| Granuloma | 1 | 2015 | 41 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2021 | 2479 | 0.030 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2015 | 56 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2011 | 2361 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2013 | 94 | 0.030 |
Why?
|
| Heart Atria | 1 | 2013 | 138 | 0.030 |
Why?
|
| Donor Selection | 1 | 2012 | 16 | 0.030 |
Why?
|
| Quality Indicators, Health Care | 1 | 2015 | 331 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2011 | 233 | 0.020 |
Why?
|
| Health Planning Guidelines | 1 | 2010 | 31 | 0.020 |
Why?
|
| Waiting Lists | 1 | 2010 | 48 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 391 | 0.020 |
Why?
|
| Recurrence | 1 | 2011 | 599 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 158 | 0.020 |
Why?
|
| Biopsy | 1 | 2010 | 376 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 302 | 0.020 |
Why?
|
| Prevalence | 1 | 2010 | 1292 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 2013 | 801 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 1471 | 0.010 |
Why?
|
| Inservice Training | 1 | 2005 | 85 | 0.010 |
Why?
|
| Adolescent | 1 | 2012 | 5950 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 5258 | 0.010 |
Why?
|